Skip to content
All articlesResearch6 min read
Research

The Peptide Popularity Report 2026

What America is actually searching for in peptides, ranked by real monthly Google demand and 12-month momentum.

A happy young adult scrolling health information on a phone at a sunlit kitchen table, curious and relaxed
Image: pru

Tirzepatide is now the most-searched peptide in the US, with about 823,000 average monthly Google searches, and it is still climbing while semaglutide slips. Across the peptides tracked here there are about 2,742,700 monthly searches. This report ranks the most-searched and the fastest-rising peptides of 2026, from real search data.

The most-searched peptides in 2026

These are the individual peptides Americans look up most, by average monthly Google searches. Each row shows what the peptide is typically used for, so you can read this as both the most-searched and the most-used list. GLP-1 weight-loss molecules dominate the top, while recovery, longevity and skin peptides fill out the rest. For the full picture by category, see the by-goal breakdown below.

2,541,700
monthly US searches across the peptides we tracked
tirzepatide
the number one most-searched peptide
5.9x
GHK-Cu, the fastest-rising peptide this year
368,000
searches for retatrutide, a peptide not yet for sale
tirzepatide
823,000
semaglutide
368,000
retatrutide
368,000
glutathione
165,000
oxytocin
165,000
nad+
135,000
sermorelin
110,000
tesamorelin
74,000
bpc-157
40,500
ghk-cu
40,500
nmn
33,100
ipamorelin
33,100
Average monthly US Google searches. Source: SEMrush, July 2026.
PeptideMonthly US searchesGoal
tirzepatide823,000Weight loss
semaglutide368,000Weight loss
retatrutide368,000Weight loss
glutathione165,000Skin & antioxidant
oxytocin165,000Sexual health
nad+135,000Cellular health
Top peptides by US search volume. Source: SEMrush, 2026.

The fastest-rising peptides

Ranked by 12-month growth in search demand, comparing the most recent quarter with the same quarter a year earlier. GHK-Cu, KPV and retatrutide are drawing the sharpest new interest.

ghk-cu
5.9x , 40,500/mo
kpv
4.7x , 6,600/mo
retatrutide
3.8x , 368,000/mo
selank
3.7x , 12,100/mo
pt-141
3.5x , 14,800/mo
semax
3.4x , 18,100/mo
mots-c
3.4x , 18,100/mo
cjc-1295
3.1x , 12,100/mo
tesamorelin
3.0x , 74,000/mo
kisspeptin
2.7x , 8,100/mo
12-month growth in monthly search demand. Source: SEMrush, July 2026.

The GLP-1 crown is shifting from semaglutide to tirzepatide

The two biggest weight-loss peptides are moving in opposite directions. Tirzepatide search demand climbed to a 12-month high, while interest in semaglutide slipped by roughly a third over the same year.

AugOctDecFebAprJunJul
Relative monthly search interest over the trailing year. Tirzepatide (dark) vs semaglutide (grey).

The newer molecule is now the one people look up first. For anyone tracking where weight-loss demand is heading, tirzepatide is the clearer signal in 2026.

What people search for, by goal

Grouping the peptides by what they are used for shows where attention sits. Weight loss leads by a wide margin, followed by recovery and muscle support.

Weight loss
1,599,300
Muscle & GH
255,400
Sexual health
202,700
Longevity
174,700
Skin & antioxidant
165,000
Recovery
99,700
Cognition
44,900
Total monthly US search demand by goal. Source: SEMrush, July 2026.

How this report was built

Figures are average monthly US Google search volume and 12-month trend per peptide, pulled from a commercial keyword dataset in July 2026. Search interest reflects curiosity, not medical use, effectiveness, or sales. Fastest-rising compares the most recent three months with the same quarter a year earlier. pru updates this report quarterly.

Common questions

What is the most popular peptide in 2026?
Tirzepatide is the most-searched peptide in the US, at about 823,000 average monthly Google searches, ahead of semaglutide and retatrutide. GLP-1 weight-loss molecules hold the top of the list.
Which peptides are growing fastest?
GHK-Cu is the fastest-rising peptide by search demand, up about 5.9x over the past year, followed by KPV, retatrutide, selank and PT-141.
How many people search for peptides?
Across the named peptides in this report there are about 2,742,700 monthly US Google searches, and the broad term peptides is itself rising quarter over quarter.
Is semaglutide or tirzepatide more popular?
Tirzepatide has overtaken semaglutide in search demand and is still rising, while semaglutide interest has slipped to a 12-month low. Tirzepatide now leads by a wide margin.
How does pru keep peptides affordable?
pru runs on an at-cost model. You pay one flat membership, and the medication is passed through at the pharmacy's price with no member markup. Because pru never marks the medication up, we have every reason to push its price down, not up. As pru grows and orders more, we negotiate lower pricing with our partner pharmacies, and those savings go straight to you. Healthcare pricing is usually hidden and inflated; pru is built to sit on your side of it: transparent, at cost, and fighting to make peptides more affordable as we scale.
Do the savings add up if I take more than one peptide?
Yes, and this is where pru's at-cost pricing saves you the most. Because pru never marks the medication up, every vial is priced at cost, so each peptide you add avoids the markup a typical provider builds in. If a physician has you on more than one peptide, or on a stack, that saving repeats on every vial, all under one flat $50 membership instead of a marked-up price on each. The more your protocol includes, the more the difference adds up, which makes doing it the right way a financially responsible choice, not an expensive one.
Sources & further reading
  1. Search volume and 12-month trend: SEMrush US database, July 2026.
  2. Compiled by pru; updated quarterly.

Want more like this?

Subscribe to get new articles delivered to your inbox. No spam, unsubscribe anytime.

All Articles